These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 6855256

  • 1. The hemodynamic effects of intra-aortic versus intravenous administration of protamine for reversal of heparin in pigs.
    Rogers K, Milne B, Salerno TA.
    J Thorac Cardiovasc Surg; 1983 Jun; 85(6):851-5. PubMed ID: 6855256
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cardiovascular effects of protamine sulfate in man.
    Shapira N, Schaff HV, Piehler JM, White RD, Still JC, Pluth JR.
    J Thorac Cardiovasc Surg; 1982 Oct; 84(4):505-14. PubMed ID: 7121041
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Cardiovascular effects of protamine sulfate are dependent on the presence and type of circulating heparin.
    Fiser WP, Fewell JE, Hill DE, Barnes RW, Read RC.
    J Thorac Cardiovasc Surg; 1985 Jan; 89(1):63-70. PubMed ID: 3965817
    [Abstract] [Full Text] [Related]

  • 7. Beneficial effect of cyclooxygenase inhibition on adverse hemodynamic responses after protamine.
    Hobbhahn J, Conzen PF, Zenker B, Goetz AE, Peter K, Brendel W.
    Anesth Analg; 1988 Mar; 67(3):253-60. PubMed ID: 3125765
    [Abstract] [Full Text] [Related]

  • 8. The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man.
    Milne B, Rogers K, Cervenko F, Salerno T.
    Can Anaesth Soc J; 1983 Jul; 30(4):347-51. PubMed ID: 6871776
    [Abstract] [Full Text] [Related]

  • 9. Thromboxane mediation of pulmonary hemodynamic responses after neutralization of heparin by protamine in pigs.
    Conzen PF, Habazettl H, Gutmann R, Hobbhahn J, Goetz AE, Peter K, Brendel W.
    Anesth Analg; 1989 Jan; 68(1):25-31. PubMed ID: 2910134
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Protamine-induced circulatory changes.
    Frater RW, Oka Y, Hong Y, Tsubo T, Loubser PG, Masone R.
    J Thorac Cardiovasc Surg; 1984 May; 87(5):687-92. PubMed ID: 6609280
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hemodynamic changes during protamine administration.
    Michaels IA, Barash PG.
    Anesth Analg; 1983 Sep; 62(9):831-5. PubMed ID: 6603799
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Randomized trial of recombinant platelet factor 4 versus protamine for the reversal of heparin anticoagulation in humans.
    Dehmer GJ, Lange RA, Tate DA, Pirwitz M, Daniel W, Fisher M, Bonnem EM.
    Circulation; 1996 Nov 01; 94(9 Suppl):II347-52. PubMed ID: 8901773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.